AdventHealth to study COVID-19 outcomes with AI biotech firm
November 23, 2020
0 Comments
AdventHealth and biotechnology company Berg are creating a biobank of demographic and clinical data from COVID-19 cases, which they'll use to study what interventions were linked with better patient outcomes.